Immediate Impact
54 standout
Citing Papers
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Works of Christina Kopp being referenced
Surgical and pathological outcome, and pathological regression, in patients receiving perioperative atezolizumab in combination with FLOT chemotherapy versus FLOT alone for resectable esophagogastric adenocarcinoma: Interim results from DANTE, a randomized, multicenter, phase IIb trial of the FLOT-AIO German Gastric Cancer Group and Swiss SAKK.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christina Kopp | 92 | 76 | 45 | 104 | 12 | 356 | |
| Quanxin Feng | 63 | 172 | 14 | 89 | 17 | 400 | |
| Aktham Hassan | 49 | 91 | 21 | 120 | 6 | 391 | |
| Mi-Young Kim | 38 | 70 | 39 | 164 | 22 | 393 | |
| Yingjie Guo | 27 | 56 | 12 | 162 | 19 | 364 | |
| Yoshitsugi Ito | 27 | 56 | 28 | 187 | 13 | 341 | |
| Celia Smith | 100 | 74 | 91 | 91 | 10 | 301 | |
| Rui Guo | 55 | 26 | 3 | 225 | 16 | 388 | |
| Min Yang | 40 | 58 | 16 | 213 | 15 | 407 | |
| Niha Zubair | 15 | 28 | 9 | 180 | 10 | 353 | |
| Le Sun | 56 | 20 | 5 | 202 | 14 | 340 |
All Works
Login with ORCID to disown or claim papers
Loading papers...